DaVita (DVA) - P/S ratio

P/S ratio at the end of 2025: 0.6001

According to DaVita's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 8.50. At the end of 2025 the company had a P/S ratio of 0.6001.

P/S ratio history for DaVita from 2001 to 2025

PS ratio at the end of each year

Year	P/S ratio	Change
2025	0.6001	-39.23%
2024	0.9876	25.28%
2023	0.7883	36.03%
2022	0.5795	-41.92%
2021	0.9977	-12.36%
2020	1.14	37.3%
2019	0.8291	10.43%
2018	0.7508	-38.34%
2017	1.22	2.88%
2016	1.18	-19.2%
2015	1.46	14.75%
2014	1.28	11.17%
2013	1.15	-19.39%
2012	1.42	35.28%
2011	1.05	-1.83%
2010	1.07	8.23%
2009	0.9910	9.02%
2008	0.9090	-20.73%
2007	1.15	-5.96%
2006	1.22	-29.75%
2005	1.74	-3%
2004	1.79	36.53%
2003	1.31	61.66%
2002	0.8108	-35.37%
2001	1.25

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Universal Health Services UHS	0.8614	16.47%	🇺🇸 USA
LabCorp LH	1.71	130.58%	🇺🇸 USA
Tenet Healthcare THC	0.9662	30.65%	🇺🇸 USA
Pediatrix Medical Group MD	0.8743	18.21%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for DaVita (DVA)

P/S ratio at the end of 2025: 0.6001